Serum oxidative stress in patients with pulmonary Mycobacterium avium complex disease
Open Access
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Role of Oxidative Stress in the Pathology and Management of Human TuberculosisOxidative Medicine and Cellular Longevity, 2018
- Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium–intracellulare complex diseaseJournal of Antimicrobial Chemotherapy, 2017
- Microbiological Persistence in Patients With Mycobacterium avium Complex Lung Disease: The Predictors and the Impact on Radiographic ProgressionClinical Infectious Diseases, 2017
- Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan1Emerging Infectious Diseases, 2016
- Oxidative stress and pulmonary fibrosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery SystemsAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Systemic oxidative stress in patients with pulmonary sarcoidosisPulmonary Pharmacology & Therapeutics, 2009
- Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosisPulmonary Pharmacology & Therapeutics, 2008
- Inflammation, Oxidative Stress and Systemic Effects in Mild Chronic Obstructive Pulmonary DiseaseInternational Journal of Immunopathology and Pharmacology, 2007
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007